Related content

Trastuzumab emtansine in the treatment of HER-2-positive metastatic breast cancer patients

By Bighin Claudia   Pronzato Paolo   Del Mastro Lucia  

Future Oncology, Vol. 9, Iss. 7, 2013-07 ,pp. : 955-957

Future Medicine

Access to resources Recommend Favorite

A multicenter trial evaluating retaspimycin HCL (IPI-504) plus trastuzumab in patients with advanced or metastatic HER2-positive breast cancer

By Modi Shanu  

Breast Cancer Research and Treatment, Vol. 139, Iss. 1, 2013-05 ,pp. : 107-113

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and safety of single agent capecitabine in pretreated metastatic breast cancer patients from the French compassionate use program

By Pierga J. Y.   Fumoleau P.   Brewer Y.   Zelek L.   Martin D.   Turpin F. L.   Goudier M. J.   Gil-delgado M.   Baticle J. L.   Namer M.   Chollet P.   Sutherland W.   Barats J. C.  

Breast Cancer Research and Treatment, Vol. 88, Iss. 2, 2004-11 ,pp. : 117-129

Springer Publishing Company

Access to resources Recommend Favorite

Trastuzumab and gemcitabine as salvage therapy in heavily pre-treated patients with metastatic breast cancer

By Bartsch Rupert   Wenzel Catharina   Gampenrieder Simon   Pluschnig Ursula   Altorjai Gabriela   Rudas Margaretha   Mader Robert   Dubsky Peter   Rottenfusser Andrea   Gnant Michael   Zielinski Christoph   Steger Guenther  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 5, 2008-10 ,pp. : 903-910

Springer Publishing Company

Access to resources Recommend Favorite

Akt expression and compartmentalization in prediction of clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab

By                  

International Journal of Oncology, Vol. 41, Iss. 4, 2012-01 ,pp. : 1204-1212

Spandidos Publications

Access to resources Recommend Favorite